MedPath
HSA Approval

CEFUROXIME-AFT POWDER FOR INJECTION 1.5G/VIAL

SIN15154P

CEFUROXIME-AFT POWDER FOR INJECTION 1.5G/VIAL

CEFUROXIME-AFT POWDER FOR INJECTION 1.5G/VIAL

January 12, 2017

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DC02

cefuroxime

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Qilu Pharmaceutical Co., Ltd.

Active Ingredients

Cefuroxime sodium 1.578g eqv Cefuroxime

1.5g

Cefuroxime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFUROXIME-AFT POWDER FOR INJECTION 1.5G/VIAL - HSA Approval | MedPath